Connect Biopharma Holdings Limited

NASDAQ:CNTB

Biotechnology

Healthcare
$0.80 -4.09%

-$0.09 today

Market cap
$50.52M
Beta
-0.21
P/E (TTM)
-4.0
EPS (TTM)
-$0.50
52W Low $0.91High $3.82

Volume 2.50M

Average 0.30M

CNTB Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Connect Biopharma Holdings LimitedNASDAQ: CNTB

Weighted Avg Shares · Q4 FY2025 · quarter ended Dec 2025

Weighted avg shares grows 0.9% year over year

Q4 FY2025 weighted avg shares of 55.66M shares rose 0.9% year over year. Over 3 fiscal years it compounded at +0.4% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterDec 2025
55.66M— QoQ
Last fiscal yearDec 2025
55.66M+0.8% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+0.9%——
1 year+0.8%——
3-year CAGR+0.4%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
55.66M USD
Year-over-year change
+0.8%
4-year CAGR
+1.6%

Weighted Avg Shares vs competitors

How CNTB compares with its peers on the latest reported figures

  • CNTB's FY2025 weighted avg shares of 55.66M shares is the 5th highest of the 9 companies compared; the peer median is 46.63M shares.
  • Its year-over-year change of +0.8% is the 7th highest of 9, against a peer median of +9.7%.
  • Over three fiscal years its annual growth of +0.4% compares with a peer median of +16.5%.
CNTB Competitors Peer median
Weighted Avg Shares for CNTB and competitors
Company Period LTM YoY 3-year CAGR
CNTXContext Therapeutics Inc.LTM Mar 202694.36M +30.6%+81.3%
STTKShattuck Labs, Inc.LTM Mar 202684.8M +66.7%+18.0%
OVIDOvid Therapeutics Inc.LTM Mar 202674.41M +4.8%+1.5%
IFRXInflaRx N.V.LTM Mar 202668.77M +14.6%+15.0%
CNTBConnect Biopharma Holdings LimitedFY202555.66M +0.8%+0.4%
ARTVArtiva Biotherapeutics, Inc.LTM Mar 202624.5M +1.8%+11.6%
KLRSKalaris Therapeutics IncLTM Mar 202621.01M +341.4%+66.1%
IMAImageneBio IncLTM Mar 202619.79M -59.0%-48.8%
STROSutro Biopharma, Inc.LTM Mar 20266.42M -22.0%+18.8%
Peer median (excluding CNTB) 46.63M+9.7%+16.5%

Competitors are the stored peer set for CNTB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00026.03M64K
Cost of Revenue00000
Gross Profit00026.03M64K
Gross Margin———100.0%100.0%
Research & Development80.5M96.63M53M29.26M37.8M
Selling, General & Admin19.01M20.81M16.05M19.23M20.34M
Operating Expenses98.11M119.32M69.06M48.49M58.14M
Depreciation & Amortization634K1.03M720K660K704K
EBITDA(201.36M)(116.74M)(61.27M)(14.75M)(54.58M)
EBITDA Margin———-56.6%-85279.7%
Operating Income(98.11M)(119.32M)(69.06M)(22.45M)(58.07M)
Operating Margin———-86.2%-90740.6%
Interest Income97.67K1.56M5.2K4.45M2.27M
Interest Expense6.91K21.03K000
Other Income / Expenses(103.89M)1.52M7.07M7.05M2.79M
Income Before Tax(202M)(117.79M)(61.99M)(15.41M)(55.28M)
Pre-Tax Margin———-59.2%-86379.7%
Income Tax Expense266K298K120K223K197K
Net Income(202.27M)(118.09M)(62.11M)(15.63M)(55.48M)
Net Margin———-60.0%-86687.5%
EPS (Basic)(25.00)(14.50)(1.08)(0.28)(1.00)
EPS (Diluted)(25.00)(14.50)(1.08)(0.28)(1.00)
Weighted Avg Shares52.27M55.04M55.07M55.21M55.66M
Weighted Avg Shares (Diluted)52.27M55.04M55.07M55.21M55.66M

Connect Biopharma Holdings Limited

NASDAQ:CNTB

Intrinsic Alpha fair value

Locked

Current Price

$0.80

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.